These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8660814)

  • 1. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
    Yamamoto N; Kumashiro R
    J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
    Yamamoto N; Homma S; Haddad JG; Kowalski MA
    Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
    Yamamoto N; Homma S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.
    Naraparaju VR; Yamamoto N
    Immunol Lett; 1994 Dec; 43(3):143-8. PubMed ID: 7721326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Gc-derived macrophage-activating factor precursor (preGcMAF) on phagocytic activation of mouse peritoneal macrophages.
    Uto Y; Yamamoto S; Takeuchi R; Nakagawa Y; Hirota K; Terada H; Onizuka S; Nakata E; Hori H
    Anticancer Res; 2011 Jul; 31(7):2489-92. PubMed ID: 21873164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
    Homma S; Yamamoto N
    Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
    Yamamoto N; Naraparaju VR; Asbell SO
    Cancer Res; 1996 Jun; 56(12):2827-31. PubMed ID: 8665521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
    Aramaki Y; Murai M; Tsuchiya S
    Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
    Yamamoto N; Naraparaju VR
    Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
    Yamamoto N; Naraparaju VR
    Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
    Homma S; Yamamoto M; Yamamoto N
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.
    Homma S; Millman I; Yamamoto N
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():137-42. PubMed ID: 1696561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.
    Yamamoto N; Naraparaju VR; Orchard PJ
    Blood; 1996 Aug; 88(4):1473-8. PubMed ID: 8695868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.